Emailwire Feed emailwire JavaScript emailwire XML
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical....more

AR101 - Launch Insight, 2018

(EMAILWIRE.COM, June 01, 2018 ) Research Cosmos', “AR101, Launch Insight, 2018” report provides comprehensive Insight about the AR101's launch. The report covers all the indications for which the AR101 is being developed and also provides the competitive landscape for the major indications. The report...more

Aptiom- Drug Insight, 2018

(EMAILWIRE.COM, June 01, 2018 ) Research Cosmos's pharmaceuticals report, "Aptiom Drug Insight, 2018" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Aptiom covering the historical...more

Aptiom - API Insight,2018

(EMAILWIRE.COM, June 01, 2018 ) Research Cosmos's, “Aptiom - API Insight, 2018” report provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Aptiom . The report also...more

Apoptosis Inhibitor -Pipeline Insight, 2018

(EMAILWIRE.COM, June 01, 2018 ) “Apoptosis Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Apoptosis Inhibitor development. The report provides detailed coverage of the...more

Apolipoprotein B (ApoB) Inhibitor -Pipeline Insight, 2018

(EMAILWIRE.COM, June 01, 2018 ) “Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Apolipoprotein B (ApoB) Inhibitor development. The report provides...more

Aplastic Anemia - Pipeline Insight, 2018

(EMAILWIRE.COM, June 01, 2018 ) "Aplastic Anemia - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Aplastic Anemia development. The report provides detailed coverage of the pipeline...more

Aplastic Anemia - Market Insight, Epidemiology and Market Forecast - 2027

(EMAILWIRE.COM, June 01, 2018 ) Research Cosmos's "Aplastic Anemia - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Aplastic Anemia epidemiology and market outlook for the 7MM. Markets Covered United States EU5 (Germany, France, Italy,...more

Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018

(EMAILWIRE.COM, June 01, 2018 ) Research Cosmos's, “Aplastic Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" report provides comprehensive insights about marketed and Phase III products for Aplastic Anemia . The report includes information of marketed products including...more

Aplastic Anemia - Epidemiology Forecast to 2027

(EMAILWIRE.COM, June 01, 2018 ) Research Cosmos's "Aplastic Anemia - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Aplastic Anemia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered United...more

Apalutamide - Launch Insight, 2018

(EMAILWIRE.COM, May 31, 2018 ) Research Cosmos', “Apalutamide, Launch Insight, 2018” report provides comprehensive Insight about the Apalutamide's launch. The report covers all the indications for which the Apalutamide is being developed and also provides the competitive landscape for the major indications....more

Anti-Mucin 1 (MUC1) Antibody -Pipeline Insight, 2018

(EMAILWIRE.COM, May 31, 2018 ) “Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed...more

Anti-Lymphotoxin -Pipeline Insight, 2018

(EMAILWIRE.COM, May 31, 2018 ) “Anti-Lymphotoxin - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Anti-Lymphotoxin development. The report provides detailed coverage of the pipeline...more

Anti-hypertension -Epidemiology Forecast to 2027

(EMAILWIRE.COM, May 31, 2018 ) Research Cosmos's "Anti-hypertension - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Anti-hypertension epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered United...more

Anti-hypertension - Market Insight, Epidemiology and Market Forecast - 2027

(EMAILWIRE.COM, May 31, 2018 ) Research Cosmos's "Anti-hypertension - Market Insight, Epidemiology and Market Forecast - 2027" report provides a detailed analysis of the Anti-hypertension epidemiology and market outlook for the 7MM. Markets Covered United States EU5 (Germany, France, Italy,...more

Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insight, 2018

(EMAILWIRE.COM, May 31, 2018 ) “Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2018” report by Research Cosmos offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Anti-Dickkopf-1 (Dkk-1) Antibody development. The report provides...more

Pages: << < [21] 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 > >>